SanofiSynthlabo News

Sanofi-aventis and Medicines for Malaria Venture announced that they have entered an agreement to launch the largest safety and efficacy study of an antimalarial drug.

Idaho's Medicaid Division is getting a nearly $115,000 share from a nationwide settlement with French drug giant Sanofi-Aventis. Attorney General Lawrence Wasden said Thursday the settlement resolves allegations that the company's Aventis Pharmaceutical unit knowingly misreported the lowest prices for three nasal sprays, Azmacort, Nasacort and ...

Pfizer and the Drugs for Neglected Diseases Initiative on Wednesday announced plans to team up in an effort to identify new drug candidates for the treatment of three tropical diseases, the Associated Press/Business Week reports.

Reporting from Washington - The Food and Drug Administration on Tuesday warned consumers not to take popular heartburn medications Nexium or Prilosec if they use Plavix, a widely prescribed blood thinner that guards against heart attack and stroke.

Nov 18, 2009 - Exelixis, Inc. today reported interim data from an ongoing phase 1 dose-escalation trial of XL147 in combination with the EGFR inhibitor erlotinib in patients with advanced solid tumors.

WASHINGTON: Federal health officials said today a popular heartburn medication can interfere with the blood thinner Plavix, a drug taken by millions of Americans to reduce risks of heart attack and stroke.

Pharmaceutical company logos and an icon symbolizing government-approved health related information are among the proposed ideas for regulating drug marketing online.

French drug maker Sanofi-Aventis SA said Monday it has received regulatory approval in France for Panenza, its vaccine against the swine flu virus.

H1N1 Swine flu deaths are back in the news and it appears that H1N1 has killed thousands more people than first thought.

Analyst Report ) recently received approval from the U.S. Food and Drug Administration for its unadjuvanted influenza A pandemic vaccine.

Amid swirling fear and finger-pointing, Sanofi Pasteur on Wednesday released its latest clinical trials showing that its H1N1 vaccine is safe and said it can deliver the 75 million doses as promised by the end of the year.

Sanofi-Pasteur is expected to produce 75 million anti-flu doses by the end of the year.

The top executive of French drug maker Sanofi- Aventis SA reached out to Boston-area researchers and biotechnology start-ups yesterday, offering "partnerships for innovation'' that could range from investing in drugs to outright acquisitions.

Sanofi-Aventis and Regeneron Pharmaceuticals Inc. said Tuesday they expanded an existing development partnership to run through 2017.

Production of H1N1 swine flu vaccine at two U.S. facilities is "working optimally" with output on the rise, the chief executive of Sanofi-Aventis said on Tuesday.

Analyst Report ) reported a third-quarter net loss of $1.015 million, or 1 cent per share, which was much better than the Zacks Consensus Estimate of a loss of 23 cents.

For most of us, the very mention of "swine flu" brings about feelings of fear, or at the very least thoughts of fevers, congestion, annoying coughs and stuffy noses.

Prasco Enters into Agreements with sanofi-aventis U.S. to Provide Sales Support and Distribution Services for Authorized Generic Versions Under the Winthrop Label in U.S. Prasco Laboratories announced today that it has entered into agreements with Winthrop U.S., a business of sanofi-aventis U.S., to provide sales support and distribution services ...

Merck CEO Richard Clark says his company is looking to do more deals than ever, perhaps "even try to double" the current rate of 50 per year.

" November 2, 2009 -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group , presented Safety of a Quadrivalent Meningococcal Vaccine When Given to Infants with Other Pediatric Vaccines at the 47th Annual Meeting of the Infectious Diseases Society of America this past weekend.